Today: 1 July 2026
Bitcoin price breaks below $90,000 as global selloff hits crypto and traders eye the next floor
21 January 2026
2 mins read

Bitcoin price breaks below $90,000 as global selloff hits crypto and traders eye the next floor

Singapore, Jan 21, 2026, 20:08 SGT

  • Bitcoin dropped beneath $90,000, a threshold investors have eyed closely throughout this year
  • The decline followed a broader risk-off shift hitting both stocks and government bonds
  • Smaller tokens and crypto-related stocks also fell, adding to the downward momentum

Bitcoin dropped under $90,000 for the first time since Jan. 9, hitting $88,894 by 9:27 a.m. in Singapore. The move echoed selloffs in stocks, long-term Treasuries, and Japanese bonds amid heightened volatility in debt markets.

The shift is significant because the sell-off hasn’t been confined to a single market. U.S. stocks experienced their sharpest one-day decline in three months on Tuesday. Bitcoin tumbled over 3% as investors dialed back risk appetite following President Donald Trump’s renewed tariff threats linked to his Greenland ambitions.

In crypto circles, $90,000 isn’t just a number. Karim Dandashy, an OTC trader at Flowdesk, called it a “critical” support level that’s held since early January. Meanwhile, ether tumbled more than 7%, Solana dropped 5.3%, Coinbase lost 5.6%, and Strategy plunged nearly 8%, according to The Business Times. The report also noted Strategy snapped up about $2.13 billion in bitcoin over the past eight days, while U.S.-listed bitcoin ETFs have attracted roughly $1.2 billion so far this year. The Business Times

Bitcoin slid to $89,929 Tuesday, then bounced back to $90,535, according to Yahoo Finance. Trading volume climbed 14%.

Bitcoin dipped below $91,000 early in European trading before finding some footing, while ethereum dropped 3.4% to $3,112, according to Barron’s. The decline comes amid rising tensions between the U.S. and Europe.

Long-dated Treasuries—U.S. government bonds with extended maturities—can move sharply when investors quickly reassess inflation, growth, or policy risk. Sudden yield jumps and rising volatility often push money out of riskier assets, and for many funds, crypto remains squarely in that category.

The recent drop has reignited a familiar debate: is bitcoin a hedge, or just another risk asset that tanks when jitters hit? “Bitcoin isn’t quite doing the thing that it’s built to do, at least in real time,” said Alex Thorn, head of research at Galaxy Digital. Meanwhile, Bitunix analyst Dean Chen told Investopedia that bitcoin is “living in a split narrative” between crypto-native buyers and the wider market.

At Davos, SkyBridge Capital’s Anthony Scaramucci called bitcoin’s recent slump “more of a timing issue than a direction issue,” expressing hopes it rebounds to somewhere between $125,000 and $150,000. He flagged the brutal downside volatility, recalling last year’s plunge after bitcoin peaked above $126,000 in October 2025, which wiped out over $19 billion in leveraged positions—traders forced to liquidate when margin calls couldn’t be met. Reuters

The road ahead isn’t straightforward. Should bond-market turmoil worsen and stocks continue to slide, key round-number marks like $90,000 could act as tripwires, forcing leveraged traders to exit and dragging prices down in sharp, brief moves. On the other hand, if yields stabilize and tariff news fades, bitcoin could rebound just as fast — it’s happened before, typically when macro traders ease off the sell pressure simultaneously.

At the moment, bitcoin’s price is reacting more to factors outside the crypto sphere—like government bonds, geopolitical events, and upcoming policy announcements. That’s leaving the market uneasy, and what looked like strong “support” levels just a week ago now seem far less reliable.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Kymera Therapeutics (KYMR) up 51% YTD as atopic dermatitis drug hits milestones
    July 1, 2026, 2:57 PM EDT. Kymera Therapeutics (KYMR) is up nearly 51% this year, way ahead of the sector's 6.4%. The stock's gain is tied to progress on KT-621, an oral STAT6 degrader for atopic dermatitis and asthma. Kymera wrapped phase IIb enrollment in the BROADEN2 AD trial six months early, aiming to have the pivotal readout by late 2026. Earlier, phase Ib data showed strong STAT6 knockdown and safety. The FDA put KT-621 on Fast Track for moderate-to-severe AD and eosinophilic asthma. Separately, trials for KT-485, in partnership with Sanofi, led to a $20 million milestone, and Kymera is still developing KT-579. Its alliances with Sanofi and Gilead are part of the company's long-term plans.
UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals
Previous Story

UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals

Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT
Next Story

Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT

Go toTop